Hormone Happenings

 
 
  • Hypoglycemia, 25 Years After DCCT A new European consortium aims to help clinicians understand the underlying mechanisms and predictors of hypoglycemia in patients with type 1 diabetes.
  • Formulary Snafus In an era of competing formularies and demands for preauthorization, taking a prescription to the pharmacy is often the beginning of a frustrating misadventure for patients and physicians alike.
  • Sometimes Doctors Need to Be Nudged A good electronic record system can help doctors remember to do what they wanted to do anyway.
  • ENDO 2018: What to Expect It's a meeting where nobodies rub elbows with somebodies, camaraderie is created, and the quantity of ideas proves that endocrinologists are 'pretty worthy people,' says Dr Richard Plotzker.
  • Defending the Cornerstones of Endocrinology The government's recent 'ban' on seven science words prompted endocrinologist Richard Plotzker to reflect on their significance in medicine and especially in the field of endocrinology.
  • Insulin Access: A Casualty of Modern Medicine? Patients used to be able to obtain their insulin easily and cheaply. But the system of modern medicine is getting in the way, and many patients are stuck (pun intended).
  • The Data Show What I Expected... In the absence of definitive clinical guidance, confirmation bias may guide decision making.
  • Derailing the 'Inevitable' Onset of Diabetes The risk of developing diabetes may be determined decades in advance, inviting opportunities to intervene and prevent the disease.
  • Hypercorrect Is a Variant of Wrong We are taught that good doctors are thorough, but is it possible to be too thorough?
  • MOC Scavenger Hunt: Worth the Effort? Maintenance of certification may not be easy, but the gains in understanding are well worth the effort.
  • New Diabetes Diagnosis, or Neglected Opportunity? A physician urges us to pay attention to hyperglycemia and prevent progression before the manifestation of clinical diabetes.
  • Choosing Commercial or Compounded Medicines Are commercially available medicines really good enough for our patients' needs? To what extent do compounded medicines have a place in our therapeutic armamentarium?
  • Following in My Footsteps: A Dad Reflects on His MD Kids For Father's Day, a physician reflects on what it's like to have raised two future physicians.
  • Soda Taxes and Chronic Disease What we eat today affects our health 10, 20, 30 years from now, but it's hard to get people to make that association, muses Dr Richard Plotzker.
  • Metformin: New Perspectives An experienced diabetologist reflects on what we know and still don't know about this common drug used to manage type 2 diabetes.
  • Anticipating ENDO An endocrinologist shares his reasons for attending the largest gathering of US endocrinologists each year.
  • Hospitalized T2DM Patients: A Missed Opportunity? A hospitalization may be the best chance to address glycemic management when a patient with type 2 diabetes is hospitalized for other problems.
  • Weight-Loss Drugs: Risks vs Benefits The arrival of new weight-loss drugs will pose some difficult decisions for prescribers.
  • The Endocrinologist's Role on the Psych Floor Providing medical care to patients on the hospital's psychiatry unit offers lessons that extend beyond that floor.
  • Endocrinology Proves Challenging for New Residents Every July brings a new cohort of medical residents, along with new challenges for attending physicians in charge of their training.
посмотреть farm-pump-ua.com

https://pillsbank.net

https://steroid-pharm.com/